Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,978 public trials 1,830 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

NCT05890352

Conditions
Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 104 locations
View Trial Details
Recruiting

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT06520098

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • San Francisco VA Medical Center, San Francisco, CA San Francisco, California, United States
  • Kansas City VA Medical Center, Kansas City, MO Kansas City, Missouri, United States
  • Durham VA Medical Center, Durham, NC Durham, North Carolina, United States
  • VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle, Washington, United States
View Trial Details
Recruiting

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

NCT06733441

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details

Related conditions